Nothing Special   »   [go: up one dir, main page]

Cheng et al., 2007 - Google Patents

Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models

Cheng et al., 2007

View HTML
Document ID
12234438370286258932
Author
Cheng I
Scearce-Levie K
Legleiter J
Palop J
Gerstein H
Bien-Ly N
Puolivaöli J
Lesné S
Ashe K
Muchowski P
Mucke L
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Many proteins suspected of causing neurodegenerative diseases exist in diverse assembly states. For most, it is unclear whether shifts from one state to another would be helpful or harmful. We used mutagenesis to change the assembly state of Alzheimer disease (AD) …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Cheng et al. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models
Linden et al. Physiology of the prion protein
Hou et al. TREM2 dependent and independent functions of microglia in Alzheimer’s disease
Blumenstock et al. Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
Ribé et al. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice
Rensink et al. Pathogenesis of cerebral amyloid angiopathy
Audouard et al. High–molecular-weight paired helical filaments from Alzheimer brain induces seeding of wild-type mouse tau into an Argyrophilic 4R tau pathology in vivo
Moechars et al. Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis
Yang et al. Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer’s disease
Kambe et al. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice
Krishnaswamy et al. Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models
Houben et al. Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model
JP2008505615A (en) Non-human transgenic animals as models for neurodegenerative diseases and their early diagnosis
Rüb et al. The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado–Joseph disease)
Schemmert et al. Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2
Islam et al. Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer’s disease
Attar et al. Assembly of amyloid β-protein variants containing familial Alzheimer’s disease-linked amino acid substitutions
US7273964B1 (en) Non-human transgenic animals for the study of neurodegenerative syndromes
Kierstein et al. Development and activity-dependent expression of neuronal marker proteins in organotypic cultures of rat visual cortex
Nakamura et al. Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains
Depp Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
Chen et al. Phagocytosis-driven neurodegeneration through opposing roles of an ABC transporter in neurons and phagocytes
Ruiz Ortega Biochemical and biophysical characterization of conformationally distinct tau protein species and their relationship with dysfunction in two models of tauopathy
Flores The Role of KCC3 in Neuronal Homeostasis
Sewell Determining the Role of Beta-Tubulin 4b in Cilia and Development